HCA, the largest for-profit hospital chain in the United States by revenue, previously estimated its year-end adjusted EBITDA, a measure of profitability, would be about $6.5 billion. HCA’s new estimates would put the figure at almost $6.6 billion.
Full fourth-quarter and 2013 financials are expected to be released Feb. 4. HCA is one of many health systems currently attending the J.P. Morgan Healthcare Conference in San Francisco, where officials plan to elaborate on results and strategy.
Through the first nine months of 2013, HCA’s adjusted EBITDA totaled almost $4.9 billion. Total revenue exceeded $8.4 billion. On Wall Street, HCA’s stock prices rose more than 52 percent throughout 2013 and are trading at more than $51 per share.
More Articles on HCA:
For-Profit Hospital Stock Report: Week of Jan. 6-10, 2013
100 Most Expensive Hospitals: National Nurses United Unveils Data
50 of the Most Powerful People in Healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
